Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Retained Earnings (2016 - 2025)

STRATA Skin Sciences' Retained Earnings history spans 15 years, with the latest figure at -$254.4 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 2.52% to -$254.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$254.4 million, a 2.52% decrease, with the full-year FY2025 number at -$254.4 million, down 2.52% from a year prior.
  • Retained Earnings hit -$254.4 million in Q4 2025 for STRATA Skin Sciences, roughly flat from -$254.5 million in the prior quarter.
  • Over the last five years, Retained Earnings for SSKN hit a ceiling of -$220.3 million in Q2 2021 and a floor of -$254.5 million in Q3 2025.
  • Historically, Retained Earnings has averaged -$235.6 million across 5 years, with a median of -$233.7 million in 2023.
  • Biggest five-year swings in Retained Earnings: dropped 1.05% in 2021 and later fell 4.94% in 2024.
  • Tracing SSKN's Retained Earnings over 5 years: stood at -$221.7 million in 2021, then dropped by 2.5% to -$227.2 million in 2022, then fell by 4.77% to -$238.1 million in 2023, then fell by 4.24% to -$248.1 million in 2024, then dropped by 2.52% to -$254.4 million in 2025.
  • Business Quant data shows Retained Earnings for SSKN at -$254.4 million in Q4 2025, -$254.5 million in Q3 2025, and -$252.8 million in Q2 2025.